HeartCare

What HeartCare does

HeartCare (心玮医疗, HKEX: 06609.HK) is a Shanghai-based, publicly listed medical device company founded in 2016 that develops and commercializes neurointerventional devices for stroke treatment and prevention. Its portfolio spans aspiration catheters, thrombectomy stents, embolization coils, flow diverters, balloon catheters, access devices, closure systems, and a left atrial appendage occluder, supported by proprietary platforms such as CATCH cascade aspiration technology and a domestic-first coated flow diverter (Ruyi). The company holds 35 NMPA product registrations and 280+ authorized patents, with additional regulatory clearances in the US (FDA 510(k)), EU (MDR), and several Asian and Latin American markets, plus MDSAP certification for global market access.

HeartCare sells primarily through a direct hospital sales force and regional distributor channels in mainland China, covering all provincial-level administrative regions and serving more than 3,000 terminal hospitals. The go-to-market model combines direct clinical engagement with academic marketing at major neurointerventional conferences (ESOC, WLNC, OCIN, LINNC Paris) and structured doctor training programs, including international exchange under the Belt and Road Stroke Prevention International Alliance. Products are quote-priced to hospitals with no publicly disclosed price list, and revenue is generated almost entirely from one-time hardware sales of sterile single-use interventional devices.

The company operates R&D and manufacturing in Nanjing (Jiangbei New Area) and California, with additional offices in Beijing and Hong Kong. Recent strategic moves include the 2023 divestiture of its interventional robotics subsidiary, the 2025 strategic partnership with Juzheng Medical to promote the Collseal closure device, MDSAP certification enabling international expansion, a 2025 positive profit warning marking first sustained profitability, and the January 2026 establishment of a brain-computer interface subsidiary (Weinao Zhilian) extending into neural-interface and intelligent rehabilitation adjacencies.

Name

HeartCare

Legal name

上海心玮医疗科技股份有限公司

Website

https://heartcare.com.cn

Company type

Public

Founded year

2016

Operating status

Operating

Headcount range

251–500 employees

Short description

HeartCare (心玮医疗) is a Shanghai-based, HKEX-listed neurointerventional medical device company that develops and sells catheters, stents, coils, flow diverters, and closure devices for stroke treatment and prevention to 3,000+ hospitals across China and select international markets.

Ownership category

akta.pro rank

Product category

Neurointerventional Medical Devices

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)

Keywords

• Neurointerventional medical devices
• Stroke treatment products
• Thrombectomy catheters
• Intracranial aneurysm devices
• Vascular closure systems

Headquarters

HQ city

Shanghai

HQ country

China

HQ region

Asia

Offices6 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. Medical Device Product Sales: HeartCare generates revenue primarily through the sale of neurointerventional medical devices including aspiration catheters, thrombectomy stents, aneurysm coils, stents, balloons, and access devices to hospitals across China and international markets

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

HeartCare (心玮医疗) is a Chinese neurointerventional medical device company that manufactures and sells a comprehensive one-stop portfolio of products for brain stroke treatment and prevention, including aspiration catheters, thrombectomy stents, embolization coils, flow diverters, balloon catheters, drug-eluting stents, embolic protection systems, vascular closure devices, left atrial appendage occluders, and access/guiding catheters. The company sells its 35+ marketed products to hospitals across all provincial-level regions of mainland China, with select products also approved in the USA, EU, Taiwan, Thailand, Ecuador, and Belarus.

Product overview

HeartCare (心玮医疗) is a medical device company offering a comprehensive one-stop solution for stroke treatment and prevention in the neurovascular intervention field. The company provides over 35 medical device products including: (1) Acute Ischemic Stroke Treatment products - 颅内血栓抽吸导管 (aspiration catheters in 6F/8F sizes, including 088 large-bore variants), 颅内取栓支架 (thrombectomy stents), 医用负压吸引泵 (aspiration pumps), 微导管 (micro catheters); (2) Hemorrhagic Stroke Treatment - 栓塞弹簧圈系统 (coil systems), 血流导向密网支架 (flow diverters), 颅内动脉瘤栓塞辅助支架 (aneurysm辅助支架), 神经血管封堵球囊导管 (occlusion balloons); (3) Neurovascular Stenosis Treatment - 颈动脉球囊扩张导管, 颅内球囊扩张导管 (including low-pressure variants), 颈动脉支架, 颅内药物洗脱支架, 栓塞保护器; (4) Neurovascular Access Devices - 远端通路导管, 支撑导管, 辅助导引导管, 经桡动脉输送导管, 神经介入微导丝; (5) Vascular Closure - 封堵止血系统 (including 8F variants), 封堵止血器; (6) Emerging Business - 左心耳封堵器系统 (LAAC), 带纤毛栓塞弹簧圈, 外周血栓抽吸导管, 静脉腔内射频闭合系统; (7) Technology Platforms - 级联抽吸技术 (CATCH) and 级联到位技术 (CATCH mini). The portfolio is supported by 280+ patents and is used in over 3,000 hospitals across China.

Differentiator

Problem solved

Functional benefit

Products and services

• Intracranial Thrombus Aspiration Catheter (颅内血栓抽吸导管) Aspiration catheter for removing clots from intracranial large vessels in acute ischemic stroke patients within 8 hours of symptom onset, available in 6F and 8F (0.088 inch large lumen) sizes.
• Vascular Closure System (封堵止血系统) Vascular closure device for femoral artery puncture hemostasis after interventional procedures, with 8F variant offering enhanced specifications.
• Intracranial Thrombectomy Stent (颅内取栓支架) / Captor Retrievable stent device for removing clots from intracranial large vessels in ischemic stroke patients within 8 hours of symptom onset.
• Left Atrial Appendage Occluder System (左心耳封堵器系统) Recapturable and re-releasable left atrial appendage occluder system for stroke prevention in non-valvular atrial fibrillation patients with CHA2DS2-VASc score ≥2.
• Embolization Coil System (栓塞弹力圈系统) Coil system with finer primary wire (0.0013in) and anti-unwinding wire (0.0011in) for intravascular embolization of intracranial aneurysms and other vascular malformations.
• Flow Diverter Device (血流导向密网支架) Flow diverter device for treatment of wide-neck intracranial aneurysms in internal carotid and vertebral arteries, redirecting blood flow at the aneurysm entrance to promote thrombosis and occlusion.
• Carotid Balloon Dilatation Catheter (颈动脉球囊扩张导管) PTA balloon dilatation catheter for percutaneous transluminal angioplasty in carotid artery stenosis.
• Neuro Balloon Dilatation Catheter (颅内球囊扩张导管) Neuro balloon dilatation catheter for treating intracranial arterial stenosis through balloon expansion, including low-pressure variants for symptomatic intracranial atherosclerotic stenosis.
• Balloon Guiding Catheter (封堵球囊导管) Balloon guiding catheter for temporary occlusion of peripheral and neurovascular vessels, particularly carotid artery.
• Distal Access Catheter (远端通路导管) Distal access catheter for introducing interventional or diagnostic devices into neurovascular and peripheral vessels, including EXTRAFLEX II variant with FDA 510(k) clearance.
• Neuro Micro Guide Wire (神经介入微导丝) Neuro micro guide wire for use with diagnostic or therapeutic catheters to reach target lesion locations in the neurovascular system.
• Support Catheter (支撑导管) Support catheter for introducing interventional or diagnostic devices into neurovascular, peripheral, and coronary vessels.
• Intermediate Guide Catheter / Navigation Sheath (辅助导引导管) Navigation sheath for assisting interventional catheters in accessing peripheral and neurovascular vessels.
• Radial Access Catheter System / Transradial Delivery Catheter (经桡动脉输送导管) Radial access catheter system for introducing interventional/diagnostic devices via transradial approach into peripheral and intracranial vessels.
• Intracranial Aneurysm Embolization Auxiliary Stent (颅内动脉瘤栓塞辅助支架) Macro closed-loop carved stent with platinum-iridium alloy tube and C-shaped buckle design for assisting coil embolization of wide-neck aneurysms in anterior circulation.
• Neurovascular Occlusion Balloon Catheter (神经血管封堵球囊导管) Neurovascular occlusion balloon catheter for temporary occlusion and flow control in neurovascular procedures.
• Coil Micro Catheter (弹力圈微导管) Micro catheter for delivering coils and diagnostic materials to peripheral and neurovascular vessels.
• Micro Catheter for Stent Delivery (支架微导管) Micro catheter for delivering interventional devices and diagnostic materials to neurovascular, peripheral, and coronary vessels.
• Embolic Protection System (栓塞保护器) Embolic protection system for capturing debris during vascular interventions in peripheral, coronary, and carotid vessels.
• Carotid Stent System (颈动脉支架) Carotid stent system for treating carotid artery stenosis through stent implantation.
• Intracranial Drug-Eluting Stent (颅内药物洗脱支架) Self-expanding intracranial drug-eluting stent for treating intracranial atherosclerotic stenosis with drug delivery capability; registration application accepted by NMPA.
• Micro Catheter (微导管) Micro catheter for selective delivery of liquids and devices to target locations in neurovascular and peripheral vessels.
• Aspiration Pump / Medical Negative Pressure Aspiration Pump (医用负压吸引泵) Aspiration pump providing -92Kpa negative pressure for extracting fluids and solids from the body during surgical procedures.
• Peripheral Thrombus Aspiration Catheter (外周血栓抽吸导管) Peripheral suction catheter for aspirating thrombi from peripheral vascular systems.
• Fibered Embolization Coil / Fibered Occlusion Coil (带纤毛栓塞弹力圈) Fibered occlusion coil with attached fibers for accelerated embolization in peripheral AVM and AVF.
• Disposable Radiofrequency Ablation Catheter (一次性使用静脉腔内射频闭合导管) Disposable radiofrequency ablation catheter for treating lower limb great saphenous vein varicosity, used with a venous RF closure generator.
• Venous RF Closure Generator (静脉腔内射频闭合发生器) Radiofrequency generator for venous ablation, working with disposable catheters for saphenous vein treatment.
• Vascular Closure System 8F (封堵止血系统8F) Vascular closure device 8F for femoral artery puncture hemostasis with enhanced specifications.
• Low-Pressure Intracranial Balloon Dilatation Catheter (颅内球囊扩张导管（低压）) Low-pressure intracranial balloon catheter for treating symptomatic intracranial atherosclerotic stenosis.
• Collseal Vascular Closure Device (封堵止血器) Collseal vascular closure device using collagen technology for femoral artery hemostasis with 28-day biodegradation, developed in partnership with Juzheng Medical.
• 7F Super Large Bore Aspiration Catheter (7F超大口径抽吸导管) 7F super large bore aspiration catheter for stroke treatment, expanding the aspiration catheter portfolio for high-burden clot cases.
• Remote Access Guidewire (远征导丝) Guidewire product for neurovascular interventions to support catheter navigation to target lesions.
• Delivery Balloon Dilatation Catheter (输送型球囊扩张导管) Delivery balloon dilation catheter for neurovascular procedures requiring balloon expansion and device delivery.

Quantifiable outcome

• Products used in over 3000 hospitals
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Belt and Road Stroke Prevention International AlliancecoreStrategic or Co-development PartnerHeartCare participates in the Belt and Road Stroke Prevention International Alliance, hosting international experts from countries including Pakistan, Kazakhstan, Colombia, Belarus, Hungary, Bosnia, South Korea, Morocco, and Iran for China visits and training programs. The alliance conducts academic exchanges and stroke prevention cooperation.
• Juzheng Medical (矩正医疗)coreStrategic or Co-development PartnerStrategic partnership for Collseal hemostatic device promotion. The collaboration integrates commercial promotion between both companies and demonstrates shared commitment to 'post-operative hemostasis safety and controllability' philosophy. HeartCare will work with Juzheng Medical on nationwide academic promotion and terminal coverage of Collseal products.

Scale indicators7 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Wallaby Medical: Wallaby Medical (which acquired Achieva Medical) is a Chinese neurovascular device company offering stent retrievers, aspiration catheters, and access devices. It competes directly with HeartCare in China's neurointerventional market with overlapping product portfolios for ischemic stroke treatment.
• Penumbra, Inc. Penumbra is a direct competitor in the neurovascular space, particularly known for its aspiration-based stroke treatment systems (Penumbra System, ACE, MAX) that compete directly against HeartCare's intracranial aspiration catheters. Both companies target acute ischemic stroke thrombectomy procedures globally.
• MicroPort NeuroTech: MicroPort NeuroTech is a Chinese-headquartered direct competitor offering intracranial stents, flow diverters (Tubridge), and other neurointerventional devices. Like HeartCare, it serves the Chinese market with growing international expansion and competes head-to-head in stroke treatment and aneurysm devices.
• Phenox GmbH: Phenox is a German-based neurovascular device company specializing in flow diverters (p64, p48MW), stent retrievers (pREset), and other neurointerventional devices. It directly competes with HeartCare in the hemorrhagic stroke and complex aneurysm treatment segments globally.

Emerging players

• Rapid Medical: Rapid Medical is an Israeli company developing adjustable neurovascular devices including stent retrievers (Tigertriever) and flow diverters (Imperative). It is an emerging direct competitor in the ischemic and hemorrhagic stroke treatment segments where HeartCare operates.
• InNeuroCo: InNeuroCo is an emerging neurovascular device company focused on intermediate catheters and access devices. Its specialty in large-bore access catheters overlaps with HeartCare's distal access catheter product line in supporting stroke thrombectomy procedures.
• Balt Group: Balt Group is a European-based neurovascular device company offering coils, flow diverters (Silk Vista Baby), and other devices for aneurysm and stroke treatment. It is an emerging player with overlapping product offerings that compete with HeartCare's portfolio internationally.

Broad incumbents

• Stryker (Neurovascular): Stryker's Neurovascular division offers a comprehensive portfolio of coils (Target), flow diverters (Surpass), stent retrievers (Trevo), and access devices, directly overlapping with HeartCare's neurointerventional product range. As a much larger incumbent, Stryker competes across both ischemic and hemorrhagic stroke treatment segments.
• Johnson & Johnson (Cerenovus): Cerenovus, J&J's neurovascular business, offers coils (Penumbra coil, Galaxy), flow diverters (Surpass Evolve), and stroke treatment devices. As a global incumbent with deep R&D resources, it competes across the same neurointerventional indications as HeartCare.
• Medtronic (Neurovascular): Medtronic's neurovascular franchise, strengthened by the acquisition of Covidien, offers a comprehensive portfolio including Solitaire stent retrievers and Pipeline flow diverters that directly compete with HeartCare's thrombectomy stents and flow diverter devices in stroke treatment and aneurysm management.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance12 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HeartCare